Compare CVNA & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVNA | MDLN |
|---|---|---|
| Founded | 2012 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3B | 37.4B |
| IPO Year | 2017 | 2025 |
| Metric | CVNA | MDLN |
|---|---|---|
| Price | $73.94 | $34.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 23 |
| Target Price | ★ $439.67 | $50.48 |
| AVG Volume (30 Days) | ★ 9.3M | 7.0M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 431.45 | N/A |
| EPS | ★ 8.45 | 0.23 |
| Revenue | $20,322,000,000.00 | ★ $28,432,000,000.00 |
| Revenue This Year | $34.66 | $10.88 |
| Revenue Next Year | $23.38 | $7.69 |
| P/E Ratio | ★ $8.96 | $154.96 |
| Revenue Growth | ★ 48.63 | 11.47 |
| 52 Week Low | $56.12 | $32.49 |
| 52 Week High | $486.89 | $50.88 |
| Indicator | CVNA | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 58.01 | 46.49 |
| Support Level | $62.23 | $35.07 |
| Resistance Level | $418.77 | $37.79 |
| Average True Range (ATR) | 3.44 | 1.32 |
| MACD | 0.86 | 0.08 |
| Stochastic Oscillator | 96.84 | 78.53 |
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.